".....................All hypothetical, but if I was the CEO wanting to take MPL to the world and put in the effort to promote, only for the Board to decide to sell prior to any confirmatory trials, I'd be pretty upset..................."
MT mentioned a couple of times that he thought $2.4 B was the right sort of price PAA should be worth as we progressed down the Phase 2/3 path. Maybe the BoD are blaming him for setting SH expectations too high and they want to consider a much smaller price tag and that upset the apple cart? If they were thinking more like $500M, that would still be a dollar a share, I wonder who of us would take that now?
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1287
-
- There are more pages in this discussion • 138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $91.22M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 20.5¢ | $174.5K | 841.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 458470 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 144453 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |